(Q35053472)

6 August 2017

1 reference

title

Plasma platelet activating factor-acetylhydrolase (PAF-AH). (English)

1 reference

6 August 2017

Ken Karasawa

1

1 reference

6 August 2017

Ayako Harada

2

1 reference

6 August 2017

Noriko Satoh

3

1 reference

6 August 2017

Keizo Inoue

4

1 reference

6 August 2017

Morio Setaka

5

1 reference

6 August 2017

1 March 2003

1 reference

Progress in Lipid Research

6 August 2017

1 reference

6 August 2017

42

1 reference

6 August 2017

93-114

1 reference

6 August 2017

2

1 reference

Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Hydrolysis of platelet-activating factor by human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Receptor-dependent metabolism of platelet-activating factor in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase activity in red blood cell-stroma from patients with cerebral thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Activity of platelet-activating factor acetylhydrolase exists in red cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The degradation of platelet-activating factor by high-density lipoprotein in rat plasma. Effect of ethynyloestradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Accumulation of platelet-activating factor acetylhydrolase in the peritoneal cavity of guinea pig after endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Cloning, expression and characterization of plasma platelet-activating factor-acetylhydrolase from guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor and related lipid mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Molecular Basis of the Interaction between Plasma Platelet-activating Factor Acetylhydrolase and Low Density Lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Mammalian platelet-activating factor acetylhydrolases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Secretion of platelet-activating factor acetylhydrolase following phorbol ester-stimulated differentiation of HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Release of platelet-activating factor in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Reduced PAF-acetylhydrolase activity is associated with postinjury multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Serum PAF acetylhydrolase and chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Evidence for the existence of the PAF acetylhydrolase mutation (Val279Phe) in non-Japanese populations: a preliminary study in Turkey, Azerbaijan, and Kyrgyzstan.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The bronchoconstrictor properties of platelet-activating factor in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Expression of platelet-activating factor receptor mRNA in human and guinea pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolases in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31-q33 near the interleukin 12 B locus by a genome-wide search in Japanese families

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor: a mediator for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Association of a G994-->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Association of a G994 --> T (Val279 --> Phe) polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor acetylhydrolase gene mutation in Japanese nephrotic children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Effects of Ginkgolide B, A Platelet-Activating Factor Inhibitor on Insulitis in the Spontaneously Diabetic Bb Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in more than 3000 healthy Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2802%2900049-8

7 January 2021

10.1016/S0163-7827(02)00049-8

Identifiers

DOI

1 reference

6 August 2017

1 reference